Researchers find promising lead that reduces autism symptoms and more

March 8, 2017, Michigan State University
Wang, MSU physiologist, and a team of researchers have found a promising lead that reduces autism symptoms and more. Credit: MSU

Fragile X syndrome is the most common cause of autism. Even though the single gene that's responsible for it was discovered in 1991, and the disease is detected by a simple blood test, there's no treatment or cure.

A team of researchers led by Michigan State University, however, has provided a promising lead in battling this disease. In the current issue of Nature Communications, the scientists identified a single protein that appears to be the culprit in causing many behavioral symptoms as well as molecular and cellular abnormalities related to Fragile X.

"We began with 600-800 potential protein targets, searching for the equivalent of a needle in a haystack," said Hongbing Wang, MSU physiologist and study co-author. "Our needle turned out to be ADCY1. When we compared levels of this protein in Fragile X to normal controls, we saw a 20-25 percent increase of ADCY1."

Subsequent tests of the team's prime-target protein on the Fragile X mouse model revealed four key results. First, by reducing the expression of ADCY1, the team eliminated many autism-like behaviors. Second, the protein's increased expression caused increased signaling in neurons. By reducing levels of ADCY1, the team dampened neuron signaling to levels within a normal range.

Lastly, neurons associated with Fragile X have excessive dendritic spines, or bumps, when compared to those in healthy patients. Reduction of the rampant protein also resulted in improving the appearance of the neurons.

Finding a single target that's responsible for so many of the causes makes the research attractive to pharmaceutical companies, Wang said.

"Our research has identified a key target and a new approach that could easily be pursued by ," he said. "We've shown an accessible target that, through treatment using NB001, suppresses activity. The next steps would be to test toxicity and optimization."

NB001, an experimental compound that also holds potential as a painkiller, delivered positive preliminary toxicity tests as well as demonstrated the ability to pass the , the protective membrane separating the bloodstream from brain extracellular fluid.

Although the study revealed a critical target and potential medicine, the findings are still years away from being considered for human clinical trials, Wang added.

In addition to potential drug development for adults, future studies could focus on children. Since the team studied adult mice, the question of catching the problem at an earlier age has yet to be addressed. If caught at an early age by a blood test, could the disease be stopped before symptoms surfaced?

Explore further: New explanation offered for symptoms of fragile X syndrome

Related Stories

New explanation offered for symptoms of fragile X syndrome

September 20, 2016
Until recently, scientists thought they understood one of the underlying causes of fragile X syndrome, the most common inherited cause of intellectual disability in the United States. The syndrome, which is associated with ...

Study implicates glial cells in fragile X syndrome

October 4, 2016
Research on fragile X syndrome, the most common inherited cause of mental retardation, has focused mostly on how the genetic defect alters the functioning of neurons in the brain. A new study focusing on a different type ...

Study shows early brain changes in Fragile X syndrome

January 31, 2017
A new study led by scientists at The Scripps Research Institute (TSRI) is giving researchers a first look at the early stages of brain development in patients with Fragile X syndrome, a disorder that causes mild to severe ...

Potential target pathway may pave the way for new therapeutic approaches for fragile X syndrome and autism

July 16, 2015
Scientists at VIB and KU Leuven have discovered that the protein APP plays a significant role in the development of fragile X syndrome (FXS) at young stages. They identified an unexpected biological pathway as a promising ...

Fragile X proteins involved in proper neuron development

June 10, 2015
Fragile X syndrome is the most common inherited intellectual disability and the greatest single genetic contributor to autism. Unlocking the mechanisms behind fragile X could make important revelations about the brain.

Recommended for you

New ALS therapy in clinical trials—drug extends survival, reverses some neuromuscular damage in animals

July 16, 2018
About 20,000 people in the United States are living with amyotrophic lateral sclerosis (ALS), also known as Lou Gehrig's disease. The invariably fatal disease kills the nerve cells that control walking, eating and breathing. ...

Convergence of synaptic signals is mediated by a protein critical for learning and memory

July 16, 2018
Inside the brain, is a complex symphony of perfectly coordinated signaling. Hundreds of different molecules amplify, modify and carry information from tiny synaptic compartments all the way through the entire length of a ...

Synapse-specific plasticity governs the identity of overlapping memory traces

July 16, 2018
Memories are formed through long-term changes in synaptic efficacy, a process known as synaptic plasticity, and are stored in the brain in specific neuronal ensembles called engram cells, which are activated during corresponding ...

'Concussion pill' shows promise in pre-clinical pilot study

July 16, 2018
In 2016, funded by a $16 million grant from Scythian, the multidisciplinary Miller School team embarked on a five-year study to examine the effects of combining CBD (a cannabinoid derivative of hemp) with an NMDA antagonist ...

Fetal gene therapy prevents fatal neurodegenerative disease

July 16, 2018
A fatal neurodegenerative condition known as Gaucher disease can be prevented in mice following fetal gene therapy, finds a new study led by UCL, the KK Women's and Children's Hospital and National University Health System ...

Rehabilitating the mind could improve outcomes after spinal cord injury

July 16, 2018
A study led by Heriot-Watt University has explored how individuals with spinal cord injuries perceive the space around them. The findings suggest additions are needed to the rehabilitation programmes adopted post-injury to ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.